BB Biotech – executive interview

BB Biotech – executive interview

BB Biotech — 9 videos in collection

More on this equity

In this interview, we speak to Dr Christian Koch, deputy head of investment management at BB Biotech (BION), the Switzerland-based investment company listed in Switzerland, Germany and Italy. Dr Koch will assume the role of head of investment management at BB Biotech at the beginning of 2025.

Dr Koch discusses the reasons for the improvement in investor sentiment regarding the biotech sector over the past year. He provides detail on some major milestones on the horizon for BB Biotech’s holdings and explains how the team’s data scientists are using big data and AI to enhance every aspect of the investment process and provide novel insights into developments in the sector.


You may also be interested in these:

Investment Companies

BB Biotech – equity proposition

Investment Companies

BB Biotech – executive interview

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.